Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Disruption of an AP-2α binding site in an IRF6 enhancer is associated with cleft lip

Abstract

Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)1 is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)2. Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G>A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P = 1 × 10−11) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2α and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2α in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Transcription factor AP-2α binds to MCS-9.7 and rs642961 disrupts its binding site.
Figure 2: MCS-9.7 shows IRF6 enhancer activity in transgenic mouse assay.

References

  1. Jugessur, A. & Murray, J.C. Orofacial clefting: recent insights into a complex trait. Curr. Opin. Genet. Dev. 15, 270–278 (2005).

    CAS  Article  Google Scholar 

  2. Zucchero, T.M. et al. Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N. Engl. J. Med. 351, 769–780 (2004).

    CAS  Article  Google Scholar 

  3. Kondo, S. et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat. Genet. 32, 285–289 (2002).

    CAS  Article  Google Scholar 

  4. Scapoli, L. et al. Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population. Am. J. Hum. Genet. 76, 180–183 (2005).

    CAS  Article  Google Scholar 

  5. Blanton, S.H. et al. Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am. J. Med. Genet. A. 137, 259–262 (2005).

    Article  Google Scholar 

  6. Ghassibe, M. et al. Interferon regulatory factor-6: a gene predisposing to isolated cleft lip with or without cleft palate in the Belgian population. Eur. J. Hum. Genet. 13, 1239–1242 (2005).

    CAS  Article  Google Scholar 

  7. Park, J.W. et al. Association between IRF6 and nonsyndromic cleft lip with or without cleft palate in four populations. Genet. Med. 9, 219–227 (2007).

    Article  Google Scholar 

  8. Schorle, H., Meier, P., Buchert, M., Jaenisch, R. & Mitchell, P.J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235–238 (1996).

    CAS  Article  Google Scholar 

  9. Milunsky, J.M. et al. TFAP2A mutations result in branchio-oculo-facial syndrome. Am. J. Hum. Genet. 82, 1171–1177 (2008).

    CAS  Article  Google Scholar 

  10. Horvath, S., Xu, X. & Laird, N.M. The family based association test method: strategies for studying general genotype–phenotype associations. Eur. J. Hum. Genet. 9, 301–306 (2001).

    CAS  Article  Google Scholar 

  11. Graham, R.R. et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. USA 104, 6758–6763 (2007).

    CAS  Article  Google Scholar 

  12. Bille, C. et al. Oral clefts and life style factors–a case-cohort study based on prospective Danish data. Eur. J. Epidemiol. 22, 173–181 (2007).

    Article  Google Scholar 

  13. Nguyen, R.H., Wilcox, A.J., Moen, B.E., McConnaughey, D.R. & Lie, R.T. Parent's occupation and isolated orofacial clefts in Norway: a population-based case-control study. Ann. Epidemiol. 17, 763–771 (2007).

    Article  Google Scholar 

  14. Mitchell, L.E. et al. Guidelines for the design and analysis of studies on nonsyndromic cleft lip and cleft palate in humans: summary report from a Workshop of the International Consortium for Oral Clefts Genetics. Cleft Palate Craniofac. J. 39, 93–100 (2002).

    Article  Google Scholar 

  15. Harville, E.W., Wilcox, A.J., Lie, R.T., Vindenes, H. & Abyholm, F. Cleft lip and palate versus cleft lip only: are they distinct defects? Am. J. Epidemiol. 162, 448–453 (2005).

    Article  Google Scholar 

  16. Marazita, M.L. et al. Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32–35. Am. J. Hum. Genet. 75, 161–173 (2004).

    CAS  Article  Google Scholar 

  17. Mossey, P. Epidemiology underpinning research in the aetiology of orofacial clefts. Orthod. Craniofac. Res. 10, 114–120 (2007).

    Article  Google Scholar 

  18. Poulin, F. et al. In vivo characterization of a vertebrate ultraconserved enhancer. Genomics 85, 774–781 (2005).

    CAS  Article  Google Scholar 

  19. Knight, A.S., Schutte, B.C., Jiang, R. & Dixon, M.J. Developmental expression analysis of the mouse and chick orthologues of IRF6: the gene mutated in Van der Woude syndrome. Dev. Dyn. 235, 1441–1447 (2006).

    CAS  Article  Google Scholar 

  20. Sharpe, J. et al. Optical projection tomography as a tool for 3D microscopy and gene expression studies. Science 296, 541–545 (2002).

    CAS  Article  Google Scholar 

  21. Cirulli, E.T. & Goldstein, D.B. In vitro assays fail to predict in vivo effects of regulatory polymorphisms. Hum. Mol. Genet. 16, 1931–1939 (2007).

    CAS  Article  Google Scholar 

  22. Vieira, A.R. et al. Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet. 1, e64 (2005).

    Article  Google Scholar 

  23. Riley, B.M. et al. Impaired FGF signaling contributes to cleft lip and palate. Proc. Natl. Acad. Sci. USA 104, 4512–4517 (2007).

    CAS  Article  Google Scholar 

  24. Thomas, J.W. et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature 424, 788–793 (2003).

    CAS  Article  Google Scholar 

  25. Schwartz, S. et al. MultiPipMaker and supporting tools: alignments and analysis of multiple genomic DNA sequences. Nucleic Acids Res. 31, 3518–3524 (2003).

    CAS  Article  Google Scholar 

  26. Margulies, E.H., Blanchette, M., Haussler, D. & Green, E.D. Identification and characterization of multi-species conserved sequences. Genome Res. 13, 2507–2518 (2003).

    CAS  Article  Google Scholar 

  27. Nickerson, D.A., Tobe, V.O. & Taylor, S.L. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745–2751 (1997).

    CAS  Article  Google Scholar 

  28. Weinberg, C.R. Methods for detection of parent-of-origin effects in genetic studies of case-parents triads. Am. J. Hum. Genet. 65, 229–235 (1999).

    CAS  Article  Google Scholar 

  29. Dudbridge, F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered. 66, 87–98 (2008).

    Article  Google Scholar 

  30. Provenzano, M.J. et al. AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma. Exp. Mol. Pathol. 83, 277–282 (2007).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We would like to thank A. Kinoshita, K. Frees, A. Mansilla, J. L'Heureux, M. Johnson, H. Morrison, G. Wehby, N. Rorick, K. Bedell and L. Powers for technical assistance and S. McConnell, D. Benton and M. DeVore for their administrative assistance. We would also like to thank A. Klingelhutz (University of Iowa) for kindly providing us with HFK cell line. This work was supported by grants from the National Institutes of Health (NIH): P50 DE16215 (J.C.M., M.L.M., B.C.S.), P30 ES05605 (J.C.M.), R37 DE08559 (J.C.M., M.L.M.), R01-DE13513 (B.C.S.), 1 UL1 RR024979-01 (J.C.M., B.C.S.), R01-CA73612 (F.E.D.), R01-HG003988 administered under Department of Energy Contract DE-AC02-05CH11231 (L.A.P.) as well as by the Intramural Research Program of the National Human Genome Research Institute (E.D.G.), in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (A.J.W.), and European Commission FP5: EUROCRAN Project (contract no. QLG1-CT-2000-01019) (M.R., P.A.M., J.L., R.P.S.-T.). A.V. was supported by the American Heart Association. M.J.H. received salary support from T32 CA078586.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

F.R. performed sequencing, SNP genotyping and statistical analysis, comparative sequence analysis, functional assays, drafted the manuscript and prepared figures and tables including supplementary material. M.L.M. conducted the statistical analyses, wrote several sections and edited the manuscript. M.E.C. and M.G. assisted with the statistical analyses. A.V., L.A.P. and D.R.F. performed transgenic mouse enhancer assay and contributed critical revisions. M.J.H. and F.E.D. provided samples for ChIP assay. E.D.G. and NISC generated sequences for comparative sequence analysis. M.R., K.C., C.B., M.M., A.J., R.T.L. A.J.W., P.A.M., J.L. and R.P.S.-T. coordinated the recruitment, phenotyping and sample collection. M.R. genotyped EUROCRAN samples. B.C.S. was involved in study design, data interpretation and contributed critical revisions. J.C.M. is the principal investigator and obtained funding, carried out patient recruitment, established key collaborations, provided study design and supervision and oversaw manuscript preparation and revision.

Corresponding author

Correspondence to Jeffrey C Murray.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Tables 1–4, Supplementary Figures 1 and 2 (PDF 4608 kb)

Supplementary Video 1

Embryo 3a (MPG 27826 kb)

Supplementary Video 2

Embryo 3b (MPG 27838 kb)

Supplementary Video 3

Embryo 3c (MPG 20900 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rahimov, F., Marazita, M., Visel, A. et al. Disruption of an AP-2α binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet 40, 1341–1347 (2008). https://doi.org/10.1038/ng.242

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.242

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing